18:02 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Ltd
- Share price
- ₹99.80
- Market cap
- ₹158.9 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 22.1×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 3Annual General Meeting 3Other Announcement 2Management Change 2Price Movement Clarification 1Merger & Restructuring 1Financial Results 1Dividend 1Annual Report 1
Time
15 announcements with these filters
18:16 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
18:09 IST
BSE
Price Movement Clarification
Bal Pharma Price Movement Clarification
Bal Pharma has clarified that the recent significant movement in its share price is purely market-driven and not due to any undisclosed price-sensitive information.
10:58 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ended March 31, 2026, in compliance with SEBI regulations.
18:16 IST
BSE
Capital Structure Change
Bal Pharma Capital Structure Change
Bal Pharma Ltd allotted 10,00,000 convertible warrants to its promoter, Mr. Shailesh Siroya, at ₹84 per warrant. This preferential issue aggregates to ₹8.4 Crore.
- Value
- ₹8.40 Cr
14:29 IST
BSE
Dividend
Bal Pharma Dividend
Bal Pharma Limited has fixed September 17, 2026, as the record date for a final dividend of Rs. 1.20 per share. Payment is scheduled for September 24.
17:48 IST
BSE
Annual Report
Bal Pharma Annual Report
Bal Pharma Limited has filed its Annual Report for the financial year 2025-26 along with the Notice of the 39th Annual General Meeting.
17:20 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Limited will hold its 39th Annual General Meeting on September 24, 2026. The record date for the final dividend is September 17, 2026.
10:48 IST
NSE
Capital Structure Change
Bal Pharma Capital Structure Change
Bal Pharma Limited clarified the 18-month tenure for utilizing net proceeds from its preferential warrant allotment. There is no change in the objects of the issue.
- Execution
- 18 months
13:34 IST
BSE
Other Announcement
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern for the period ending December 31, 2025. This disclosure provides details on share distribution among promoters and public.
18:38 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced changes in director designations, effective October 1, 2026. These changes were approved during the board meeting held on August 12, 2026.
18:37 IST
NSE
Merger & Restructuring
Bal Pharma Merger & Restructuring
Bal Pharma is incorporating a new Joint Venture in the Philippines to distribute pharmaceutical products. The company will hold a 65% equity stake in this entity.
18:27 IST
BSE
Financial Results
Bal Pharma Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 450.0% YoY
Bal Pharma Ltd reported revenue from operations of ₹88.6 Cr (+34.4% YoY) and net profit of ₹1.1 Cr (+450.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +450.0% YoY
16:55 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd released the Scrutinizer's Report on postal ballot voting results regarding the proposed preferential issue of 1,000,000 warrants to the promoter.
16:53 IST
BSE
Capital Structure Change
Bal Pharma Capital Structure Change
Bal Pharma's shareholders approved a special resolution via postal ballot to issue 10,00,000 warrants to the promoter on a preferential basis.